KBL51/105 conical twin-screw extruder have temperature-controller, vacuum exhaust device, suitable for the production of pipes, sheets and profiles. It has forced extrusion, high-quality, wide adaptability, long life, small shearing speed, material not easy broken down, good mixing performance, powder direct molding and so on.
| Screw diamete(rmm) Â |
51/105Â Â Â | motor power(kw) | 18.5 | center height of screw(mm) |
1000Â Â Â Â Â Â |
| screw direction  |
opposite      outward | installation power (kw) | 40 | weight(kg) | 3500 |
| speed of screw rotation (r/min) | 1-38 | Max. capacity(kg/h) | 150 | dimension(L*W*H) (mm) | 3320×1050×2157 |
| length of screw (mm) Â |
1050 | quantity of barrel heating(pcs) | 4 | Â | Â |
| structure of screw | conical-shaped mesh | heating | die-casting aluminum+ ceram heating  |
 |  |
KBL51/105 conical twin-screw extruder have temperature-controller, vacuum exhaust device, suitable for the production of pipes, sheets and profiles. It has forced extrusion, high-quality, wide adaptability, long life, small shearing speed, material not easy broken down, good mixing performance, powder direct molding and so on.
| Screw diamete(rmm) Â |
51/105Â Â Â | motor power(kw) | 18.5 | center height of screw(mm) |
1000Â Â Â Â Â Â |
| screw direction  |
opposite      outward | installation power (kw) | 40 | weight(kg) | 3500 |
| speed of screw rotation (r/min) | 1-38 | Max. capacity(kg/h) | 150 | dimension(L*W*H) (mm) | 3320×1050×2157 |
| length of screw (mm) Â |
1050 | quantity of barrel heating(pcs) | 4 | Â | Â |
| structure of screw | conical-shaped mesh | heating | die-casting aluminum+ ceram heating  |
 |  |
Lenvatinib is a synthetic, orally available inhibitor of vascular endothelial growth factor receptor 2 (VEGFR2, also known as KDR/FLK-1) tyrosine kinase with potential antineoplastic activity. Lenvatinib blocks VEGFR2 activation by VEGF, resulting in inhibition of the VEGF receptor signal transduction pathway, decreased vascular endothelial cell migration and proliferation, and vascular endothelial cell apoptosis.
Lenvatinib is orally available multi-kinase inhibitor and antineoplastic agent that is used in treatment of advanced, metastatic medullary thyroid cancer and refractory renal cell carcinoma. Lenvatinib is associated with a modest rate of serum enzyme elevations during treatment and has been implicated to rare instances of clinically apparent, acute liver injury some of which have been fatal.
Lenvatinib Cas 417721-36-9,Lenvatinib Cas 796848-79-8,Lenvatinib Cas 52671-64-4,Lenvatinib Cas 17609-80-2
 Shandong Haohong Biotechnology Co., Ltd. , https://www.haohongpharma.com